Chardan Highlights Alumis’s (ALMS) Potential After Envudeucitinib Hits All Phase 3 Endpoints in Psoriasis Trials
Alumis Inc. (NASDAQ:ALMS) is one of the new stocks on the rise.
Alumis Inc. (ALMS)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Samsara BioCapital Srini Akkaraju And Michael Dybbs | 4,801,370 | $19,157,466 | 2.5% | |
| 2. | Cormorant Asset Management Bihua Chen | 2,147,396 | $8,568,110 | 0.59% | |
| 3. | SR One Capital Simeon George | 1,959,896 | $7,819,985 | 1.13% | |
| 4. | OrbiMed Advisors Samuel Isaly | 1,926,423 | $7,686,428 | 0.18% | |
| 5. | Woodline Partners Michael Rockefeller And Karl Kroeker | 1,751,150 | $6,987,089 | +810% | 0.03% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.00 | 588,235 | $9,999,995.00 | 1,853,488 | 2026-01-09 | Filing | |
| $17.00 | 294,117 | $4,999,989.00 | 2,908,332 | 2026-01-08 | Filing | |
| $17.00 | 117,647 | $1,999,999.00 | 5,702,536 | 2026-01-08 | Filing | |
| $17.00 | 294,117 | $4,999,989.00 | 2,908,332 | 2026-01-08 | Filing | |
| $17.00 | 117,647 | $1,999,999.00 | 5,702,536 | 2026-01-08 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,103,290 | $40,048,110 | 0% | |
| 2. | 893,107 | $8,716,724 | 6.76% | |
| 3. | 113,997 | $1,112,611 | 0% | |
| 4. | 26,667 | $260,270 | 0.03% | |
| 5. | 15,840 | $154,598 | 0.01% |
News See All
10 New Stocks on the Rise
On January 21, Lynn Martin, NYSE president, joined CNBC's Sara Eisen to discuss the IPO landscape for 2026.
HC Wainwright & Co. Hikes Alumis Inc. (ALMS)'s Price Target To $40 From $20, Reiterates Buy Rating
Alumis Inc. (NASDAQ:ALMS) is among the 14 best booming stocks to buy right now. On January 9, HC Wainwright & Co.
14 Best Booming Stocks to Buy Right Now
In a report released on January 9, Goldman Sachs said that it expects the index to rally 12% in 2026.
11 Best New Penny Stocks to Buy Right Now
On July 28, the Opening Bid team at Yahoo Finance and Victoria Fernandez, chief market strategist at Crossmark Global Investments, discussed the rise in cheap stock trading and what it can mean for the...
Morgan Stanley Resumes Coverage of Alumis (ALMS) with $23 PT
On Monday, Morgan Stanley resumed its coverage of Alumis Inc.
Why Alumis (ALMS) Stock Is Advancing Today
Due to concerns about Alumis' cash reserves and competition, ALMS is changing hands for slightly above the value of its cash reserves, Oppenheimer analyst Jeff Jones reported.
Hedge Fund Resource Center Billionaire Hedge Funds
